Improving cure rates of B-cell acute lymphoblastic leukemia with chimeric antigen receptor T-cells
{{output}}
Chimeric antigen receptor T cell (CAR T) therapy was first approved for the treatment of children and young adults with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL). Since then, two additional CAR T products have been approved for adult R/R B-A... ...
